ECM
HGEN

Endurant Capital Management’s HUMANIGEN, INC. HGEN Stock Holding History

Endurant Capital Management’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-154,613
Closed -$575K – 89
2021
Q4 		$575K Buy
+154,613
New +$905K 0.14% 65

Other funds holding HGEN

VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Endurant Capital Management's HGEN Position: Q1 2022 in Review

Endurant Capital Management sold out of HUMANIGEN, INC. (HGEN) in Q1 2022, closing a stake of 154,613 shares — an estimated $575K sold.

Endurant Capital Management first reported a position in HGEN in Q4 2021 and held it in 1 quarter. The position peaked at $575K in Q4 2021. 83 funds tracked by Wall St. Rank hold HGEN as of Q1 2022.

  • Endurant Capital Management reported no remaining HUMANIGEN, INC. position as of Q1 2022 after selling out during the quarter.
  • Endurant Capital Management sold 154,613 HUMANIGEN, INC. shares in Q1 2022, an estimated $575K.
  • Endurant Capital Management first reported a position in HUMANIGEN, INC. in Q4 2021 and held it in 1 quarter.
  • Endurant Capital Management's HUMANIGEN, INC. position peaked at $575K in Q4 2021.
  • 83 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q1 2022.

Based on Endurant Capital Management's 13F filing for Q1 2022, filed 16 May 2022.